Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Schizosaccharomyce pombe" patented technology

Traditional Chinese medicinal preparation for treating damp turbidity and spleen stagnation type hyperlipidemia

A traditional Chinese medicinal preparation for treating damp turbidity and spleen stagnation type hyperlipidemia is prepared by using malt, millet sprout, rice grain sprout, Gynostemma pentaphylla, lotus leaf, corn silk, Chinese yam, dried orange peel, cassia seed, hawthorn fruit, Mythic Fungus, wolfberry fruit, Poria cocos, white hyacinth bean, lotus seed, black soybean, jujube, Coriolus versicolor(L.ex Fr.)Quel., dahurian angelica root, coix seed, Ligustri Lucidi Fructus and Semen Phaseoli. A preparation method of the traditional Chinese medicinal preparation comprises the following steps: decocting the above raw materials with water, cooling the obtained filtrate to room temperature, and inoculating Saccharomyces cerevisiae or Sac.carlsbergensis Hansen or Schizosaccharomyces pombe or Nematspora gossypii, wherein the amount of the above inoculated bacterium accounts for 1-5% of the volume of the water extract filtrate; fermenting at 20-32DEG C for 30-48h to obtain a suspension fermentation liquid, concentrating to obtain an extract paste, and drying at 80-100DEG C; and grinding the dried extract paste to fine powder having a particle size of 150mum or less to obtain an inactivated thallium and metabolite fine powder, detecting the protein content reaching 40% or more, and filling to a capsule. The clinic cure rate, the significant efficiency, the effective rate and the total effective rate of the preparation are 32.90%, 23.81%, 32.14% and 92.86% respectively.
Owner:ZIBO DEV ZONE YADA PHARMA

Recombinant Vaccine from gE, gI, and gB Proteins of the Varicella-Zoster Virus for the Treatment and Prevention of Multiple Sclerosis

Varicella-zoster virus belongs to the herpesvirus family and its main host are humans, producing 2 different diseases: varicella in children and young adults and zoster in elder or immunodepressed subjects. We reported in the scientific medical literature the unexpected finding that the role of varicella-zoster virus in the pathogeny of Multiple Sclerosis (Archives of Neurology 61: 529-532). This finding allows us to foresee the use of a vaccine against this virus with preventive and therapeutic ends for multiple sclerosis which eventually could also be applicable in the prevention of varicella and zoster. Currently the only vaccine used in humans is that produced by attenuated live varicella-zoster viruses, this latter feature thus avoiding its therapeutic use in multiple sclerosis, wherein the chronic disease is caused by periodic exacerbations of the virus which remains latent in the host, therefore by injecting an attenuated and viable virus the infection may be exacerbated and promote the very latency of the vaccine virus.
In our studies the most conspicuous genes of the varicella-zoster virus found in multiple sclerosis patients were the ones corresponding to the genes ORF31 (gB), ORF67 (gI) and ORF68 (gE). The recombinant vaccine which is the subject of this patent is built up by the proteins generated by these genes inserted in a plasmid vector of pNMT1-TOPO in order to transform Schizosaccharomyces pombe and thus obtaining the recombinant viral proteins which build up the vaccine.
This vaccine, by being made from recombinant viral proteins eliminates the risks associated to the use of vaccines from attenuated viable viruses. Likewise, the use of these recombinant viral proteins is specific and sensitive to serological tests for the diagnosis of infections caused by the varicella-zoster virus.
Owner:SOTELO MORALES JULIO EVERARDO +2

Edible alcohol fermentation production process

The invention discloses an edible alcohol fermentation production process. The edible alcohol fermentation production process comprises the following steps that longans and red dates are prepared according to the weight part ratio of 1:10 to 1:3; the raw materials longans and red dates are cooked in a steam cooking pot according to the ratio, then tap water is added into the longans and red dates which are cooked, even stirring is performed, and then smaller lumped koji powder is added and evenly stirred to make thick mash; the thick mash is added into a saccharifying enzymolysis tank, and then smaller lumped koji is added and evenly stirred for saccharification; then the mixture is transferred into an enzymolysis tank, aspergillus niger pectinase is added, and enzymolysis is performed to obtain secondary thick mash; a schellozosaccharomyces pombe strain is inoculated to the secondary thick mash, then the secondary thick mash is put in an alcohol fermentation tank, peptone is added, and stirring and fermentation are performed to obtain fermented mash; the fermented mash is distilled by using a five-tower secondary differential-pressure distillation device to obtain an edible alcohol finished product. The brewed edible alcohol has good qi tonifying and blood benefiting effects, has a higher nutritive value and has a sweet and good taste.
Owner:崇州市富易生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products